Epilepsy is a neurological condition that affects millions of people worldwide, characterized by recurrent seizures caused by abnormal brain activity. These seizures can range from mild episodes of ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

BRYAN, Texas (KBTX) - THC and CBD were the focal point coming into the Texas special session. Just today, the Senate advanced Senate Bill 5 to the House, which would ban the use of all consumable THC ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn’t stop seizures for everyone and ...

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Antiseizure medications help the majority of people with focal epilepsy, a common form of the neurological disorder. Yet most will still have episodes for at ...

Focal treatment-resistant epilepsy improves over time, but seizure reduction appears to be unrelated to specific medications ...

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer ...

Xenon Pharmaceuticals (($XENE)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Randomized, ...

Most TSC caregivers plan to continue Epidiolex due to benefits like fewer seizures and improved cognition. New data at AES 2024 underscores Epidiolex's positive impact on TSC patients' health and well ...